"Cancer signal not detected." That was the happy finding of my Galleri multi-cancer early detection (MCED) blood test from the Silicon Valley biotech company GRAIL. The Galleri test presages an ...
Amgen and Abbott are ditching horseshoe crab blood for synthetic alternatives — a win for a 450-million-year-old species ...
The greater need for laboratory efficiency requires technicians to conduct more tests. However, variations introduced by human operators, such as differences in device insertion and alignment, can ...
In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...
The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other therapeutics represents one of the most consequential regulatory developments in ...
On October 24, scientists from around the world will come to San Antonio to discuss how testing on monkeys might one day lead to an AIDS cure. They’ll be talking baboons, macaques, and vervets at the ...
BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc. (Saladax) is pleased to announce the signing of a global distribution agreement with Beckman Coulter, Inc. to distribute the MyCare™ ...
A new technique called slug flow microextraction makes it possible to quickly detect the presence of drugs or to monitor certain medical conditions using only a single drop of blood or urine. The ...
When Pieter van Rooyen sold Edico Genome to Illumina four years ago for $100 million, it was an early example of San Diego’s semiconductor and software expertise spilling over into the region’s ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...
EVERETT, Wash.--(BUSINESS WIRE)--Fluke Biomedical announced the OneQA test and workflow automation software now supports the top-selling ProSim 8 multifunction patient simulator. Fluke Biomedical ...
Talis Biomedical, which is developing diagnostic tests for COVID-19 and other infectious diseases, filed on Friday with the SEC to raise up to $150 million in an initial public offering. The company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results